No Data
Day One Biopharmaceuticals Insider Sold Shares Worth $320,226, According to a Recent SEC Filing
We Think Day One Biopharmaceuticals (NASDAQ:DAWN) Can Afford To Drive Business Growth
Day One Biopharm Price Target Maintained With a $40.00/Share by Piper Sandler
Piper Sandler Keeps Their Buy Rating on Day One Biopharmaceuticals (DAWN)
Insider Selling: Director Saira Ramasastry Sells Shares of Day One Biopharmaceuticals Inc (DAWN)
Day One Biopharmaceuticals(DAWN.US) Director Sells US$131.88K in Common Stock